Beta Bionics' Mint Patch Pump FDA Clearance Signals a New Era for Intelligent Insulin Delivery Devices On September 14, 2026, Beta Bionics, Inc. (Nasdaq: BBNX) announced U.S. Food and Drug Administ... Read News
Published date : October 2, 2026
Novo Nordisk Signs €1.17B Pact with Nanexa for Long-Acting Injectable Drug Delivery Tech STOCKHOLM, Sweden September 28, 2026 Novo Nordisk (NYSE: NVO) has entered into a global licensing agreement... Read News
Published date : September 28, 2026
GLP-1 Use Hits Record 11% of US Adults as Medicare Bridge Program Expands Access WASHINGTON, D.C., United States July 8, 2026, the share of U.S. adults using GLP-1 receptor agonist medications for... Read News
Published date : September 24, 2026
FDA Grants Priority Review to Insmed's Arikayce Inhaled Antibiotic for MAC Lung Disease BRIDGEWATER, New Jersey, U.S. September 21, 2026, the U.S. Food and Drug Administration (FDA) has accepted a... Read News
Published date : September 21, 2026
FDA Greenlights First China-Originated Intravenous Anesthetic, Signaling a New Competitive Era in the Global Anesthesia Drugs Landscape On June 1, 2026, the U.S. Food and Drug Administration grante... Read News
Published date : August 26, 2026
Guardant Health Appeals IP Ruling, Shields Key Blood Tests From Royalty Impact PALO ALTO, California August 24, 2026 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, annou... Read News
Published date : August 25, 2026
China's BYHEALTH Expands Vitamin and Supplement Portfolio to Address Urban Stress-Linked Health Conditions SINGAPORE — August 19, 2026 — China's BYHEALTH, one of the country's leading dietary supp... Read News
Published date : August 19, 2026
Procter & Gamble to Acquire Supplement Brand Thorne for $3.8 Billion in Cash SUMMERVILLE, SC, United States — August 12, 2026 — Procter & Gamble (P&G) has entered into a definitive agreement to ac... Read News
Published date : August 12, 2026
Moderna Surpasses Q2 2026 Revenue Forecasts Ahead of Critical FDA mRNA Flu Vaccine Ruling BENGALURU, India — July 31, 2026 — Moderna, Inc. reported second-quarter 2026 revenue of USD 145 million,... Read News
Published date : July 31, 2026
Summit, Merck Face Heightened FDA Scrutiny as China-First Oncology Trials Reshape Drug Approval Landscape NEW YORK, United States — July 27, 2026 — Summit Therapeutics and Merck & Co. are confront... Read News
Published date : July 26, 2026